Outlier Capital 5.0 15 ideas

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
Outlier Capital provides a weekly update on a concentrated portfolio of 11 stocks targeting 10x returns. The author reports 8 positions in positive territory, with top performers SIVE (+176%) and POET (+139%), and adds two new positions (AMSC, HPS) while closing CIFR. The strategy emphasizes asymmetric risk-reward and conviction-driven holding through volatility. • 8 out of 11 positions are positive on an unrealized basis, with SIVE, POET, IQE, and LWLG as top gainers. • New additions: AMSC and HPS after a 'Defense and Grid Supercycle' thesis; CIFR was closed and capital reallocated into HPS. • Laggards include HIMS (-16.7%) and SMR (-9.9%), but the author remains committed to the portfolio thesis. • The portfolio is conviction-driven; the author does not intend to trade short-term volatility unless fundamentals change.

April 26, 2026 at 18:01

TLDR
The author argues that IQE, a compound semiconductor epitaxy supplier, is being mispriced by the market due to its recent financial weakness, while its positioning in AI photonics (InP, quantum dot lasers, VCSELs) and strategic review optionality (potential Taiwan sale or company sale) create substantial upside. The sell-off offers an entry point for investors willing to tolerate near-term risk for long-term AI infrastructure exposure. • IQE is a supplier of advanced epitaxial wafers for photonics, wireless, and power applications, with growing relevance to AI optical interconnects via InP and quantum dot lasers. • H1 2025 results were weak (revenue -31%, adjusted EBITDA negative), but the January 2026 trading update showed recovery signs with FY2025 revenue at ~£97m and improved order book. • The company has real ecosystem credibility through partnerships with Quintessent, Lumentum, and a broad customer base, not just thematic hype. • A strategic review is underway, including potential sale of Taiwan operations or the whole company, which could deleverage the balance sheet and catalyze a rerating. • The bull case requires photonics becoming the core revenue driver, visible commercial scaling of AI-related materials, and improvement in operating leverage. • The author explicitly holds a long position in IQE, viewing it as a 'flawed but strategically relevant' name with asymmetric upside if the AI photonics thesis materializes.

April 25, 2026 at 14:03

TLDR
Outlier Capital highlights Trio-Tech ($TRT) as a deep value play in AI semiconductor testing, citing 82% YoY revenue growth and a low 2.2x P/S ratio versus peers like Aehr Test Systems. The author is beginning to build a long position via dollar-cost averaging to manage micro-cap volatility, expecting a re-rating as the AI tailwind materializes on the income statement. • $TRT has a market cap of $110M, TTM revenue of $49M, and 82% YoY growth, trading at just 2.2x P/S. • The valuation gap versus peer $AEHR (historically ~60x forward P/S) is described as a 'canyon.' • The author is beginning to build a long position slowly via dollar-cost averaging to mitigate micro-cap volatility. • The thesis is that TRT's legacy burn-in board business is now mission-critical for next-gen AI GPUs, driving a potential re-rating.

April 24, 2026 at 12:31

TLDR
The article argues that the U.S. is entering a coordinated defense-and-grid supercycle, driven by the Pentagon's FY2027 budget request and a Defense Production Act determination for grid infrastructure. The author identifies five specialized companies poised to benefit from bottlenecks in autonomy, munitions, power electronics, and transformers, but only discloses planned long positions in HPS and AMSC. • Pentagon FY2027 budget request totals ~$1.45 trillion, emphasizing drones, autonomy, munitions, shipbuilding, and missile defense. • White House Section 303 DPA determination declares grid infrastructure (transformers, conductors, switchgear) essential to national defense. • Defense readiness and AI-scale power demand are converging, making grid hardening a national security theme. • The author believes asymmetric upside lies in smaller companies tied to bottlenecks, not just prime defense contractors. • Five high-upside names are discussed: AMSC, KTOS, POWL, AVAV, and HPS.A, each with different exposures to defense and grid catalysts. • The author discloses a plan to go long HPS and AMSC, but does not confirm current positions in the other names.

April 23, 2026 at 09:39

TLDR
The article argues that the U.S. is entering a coordinated defense-and-grid supercycle, driven by the Pentagon's FY2027 budget request and a Defense Production Act determination for grid infrastructure. The author identifies five specialized companies poised to benefit from bottlenecks in autonomy, munitions, power electronics, and transformers, but only discloses planned long positions in HPS and AMSC. • Pentagon FY2027 budget request totals ~$1.45 trillion, emphasizing drones, autonomy, munitions, shipbuilding, and missile defense. • White House Section 303 DPA determination declares grid infrastructure (transformers, conductors, switchgear) essential to national defense. • Defense readiness and AI-scale power demand are converging, making grid hardening a national security theme. • The author believes asymmetric upside lies in smaller companies tied to bottlenecks, not just prime defense contractors. • Five high-upside names are discussed: AMSC, KTOS, POWL, AVAV, and HPS.A, each with different exposures to defense and grid catalysts. • The author discloses a plan to go long HPS and AMSC, but does not confirm current positions in the other names.

April 23, 2026 at 09:39

TLDR
The article argues that Nynomic (M7U) is a messy, underfollowed small-cap with a recovery setup after a tough 2025 year. The author highlights improving Q4 2025 trends, management guidance for FY2026 margin recovery, and the potential for the LayTec subsidiary to benefit from rising optoelectronics demand. The market still prices the stock for past problems, creating an opportunity if the turnaround materializes. • Nynomic reported weak preliminary FY2025 results (€92.6M revenue, ~2% EBIT margin) but Q4 showed improvement. • Management guides FY2026 revenue of €100–105M and EBIT margin of 6%–8%, signaling recovery. • Key subsidiary LayTec provides metrology for compound semiconductors and silicon thin films, an area tied to AI-era photonics. • AIXTRON's strong Q1 2026 order intake (up ~30% YoY) supports the thesis that optoelectronics demand is inflecting. • The author believes the market is backward-looking and ignores the cost restructuring and potential visibility from the order backlog. • Risks include volatile capex, geopolitical tensions, and the need to prove the recovery is durable.

April 22, 2026 at 12:09

TLDR
The author argues that LPKF Laser (ticker LPK) is a uniquely positioned small-cap company in the glass-based advanced packaging transition, with its LIDE technology already inside major semiconductor players. Despite weak 2025 financials, the author believes the market undervalues LPKF's strategic role, and expects production orders from 2027 to drive a rerating. The author explicitly discloses a long position. • LPKF's LIDE technology enables high-precision glass processing for semiconductor advanced packaging, with over 80% of major global players using it in validation. • The company is expanding beyond glass vias into adjacent processes like singulation, bonding, and co-packaged optics. • CEO Klaus Fiedler expects mass production of glass substrates from 2027, with initial equipment orders appearing in Q1 2026. • 2025 revenue fell to €115.3m and EBIT was -€13.5m, but financial runway (73.2% equity ratio, refinanced loan) supports the thesis. • The author views the current ~€300m market cap as too low if glass adoption scales, making LPKF a potential multi-bagger. • Key catalysts: Q1 2026 report on April 30, order intake, Electronics segment profitability, and customer moves from qualification to production.

April 22, 2026 at 09:05

TLDR
Outlier Capital argues that Sivers Semiconductors (SIVE) is one of the most credible small-cap ways to play the AI optical stack, citing real photonics product traction, ecosystem partnerships (POET, Jabil, Marvell/NVIDIA), and a potential Nasdaq dual listing as catalysts. However, the author cautions that the company is still early in its transformation — product revenue is small, cash flow negative, and the stock has already rerated — so further upside depends on execution, not just narrative. • Sivers has real photonics technology (DFB lasers) used in AI optical interconnects, with growing product revenue and partnerships (POET, Jabil, WIN Semiconductors). • The supply chain chain (Sivers→POET→Celestial AI→Marvell→NVIDIA) gives the thesis substance, though direct NVIDIA exposure is not confirmed. • Financials are still immature: most revenue is NRE/development, product sales are small, and cash flow remains negative, but photonics product revenue is inflecting positively. • A potential Nasdaq dual listing is highlighted as a major bullish catalyst that could expand the investor base and liquidity, but also brings PCAOB audit risks. • The author is constructive but selective: the stock is no longer cheap, and the next leg requires productization, better financial quality, and capital discipline. • The author explicitly discloses being long SIVE, indicating a personal conviction in the asymmetric risk/reward over the next 18-24 months.

April 21, 2026 at 15:47